Latest Drug Approvals news
FDA Approves First Treatment for Thyroid Eye Disease
posted July 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Tzield for Children With New Stage 3 Type 1 Diabetes
posted July 1st
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Oral Utebzi Antibiotic for Complicated Urinary Tract Infections
posted June 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Welireg With Pembrolizumab for Renal Cell Carcinoma
posted June 18th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Pembrolizumab-Belzutifan Tied to Improved Disease-Free Survival in Renal Cell Carcinoma 
Comparable Progression Risk Seen With Ablation Versus Surgery for T1a Renal Cell Carcinoma 
Most Speakers at FDA Advisory Committee Meetings Support Drug Approval 
Countries Involved in U.S. Clinical Trials Do Not Gain Timely Access to Approved Medicines Related Articles
FDA Picks George Tidmarsh to Head Center for Drug Evaluation and Research 
Approved-Label Populations for New Drugs Broader Than Trial Populations 
FDA Expands Indication of Dust Mite Allergy Drug to Include Young Children Monthly Specialist Briefings
Stay Connected
